Related Experiment Video
Updated: Aug 13, 2025

06:34
Author Spotlight: Stimulation-Based Approach to Improve Cerebral Blood Flow in Alzheimer's Model
Published on: June 2, 2023
1.2K
[Neurology: what's new in 2022]
Céline Bouvy1, Leonardo Caranzano1, Gilles Allali2
1Service de neurologie, Département des neurosciences cliniques, Centre hospitalier universitaire vaudois et Université de Lausanne, 1011 Lausanne.
Revue Medicale Suisse
|January 20, 2023
Summary
In 2022, new treatments emerged for refractory myasthenia gravis and epilepsy secondary to stroke. Advances included thrombectomy for basilar artery occlusion and insights into Epstein-Barr virus and multiple sclerosis.
Area of Science:
- Neurology
- Clinical Neuroscience
- Medical Research
Context:
- 2022 saw significant advancements in neurological disorder treatments.
- Focus on refractory myasthenia gravis, epilepsy, and multiple sclerosis.
- Emerging research in cerebrovascular disorders and neurodegenerative diseases.
Purpose:
- To summarize key 2022 breakthroughs in neurology.
- Highlight novel therapeutic developments and etiological discoveries.
- Provide an overview of critical findings in stroke, epilepsy, and autoimmune neurological conditions.
Summary:
- Lamotrigine identified as optimal treatment for stroke-related epilepsy in patients 45+.
- Thrombectomy efficacy confirmed in selected basilar artery occlusion cases.
- Causal link between Epstein-Barr infection and multiple sclerosis established.
- Subcutaneous levodopa administration shows promise for Parkinson's disease.
- Anti-CGRP antibodies demonstrate high efficacy and tolerability for migraine treatment.
Impact:
- Potential for improved patient outcomes in epilepsy and stroke.
- New therapeutic avenues for multiple sclerosis and Parkinson's disease.
- Enhanced management strategies for refractory myasthenia gravis and migraines.
More Related Videos
Related Concept Videos
Neurogenesis and Regeneration of Nervous Tissue
944
In the CNS, neurogenesis, the birth of new neurons from stem cells, is limited to the hippocampus in adults. In other regions of the brain and spinal cord, neurogenesis is almost non-existent due to inhibitory influences from neuroglia, especially oligodendrocytes, and the absence of growth-stimulating cues. The myelin produced by oligodendrocytes in the CNS inhibits neuronal regeneration. Furthermore, astrocytes proliferate rapidly after neuronal damage, forming scar tissue that physically...
944
Neuroplasticity
663
Neuroplasticity reflects the brain's remarkable capacity to adapt and evolve, responding dynamically to learning, experiences, or injury by reorganizing its neural circuitry. This reorganization involves creating new neural connections and refining old ones through a series of biological processes that contribute to the brain's lifelong development and adaptability.
663

